The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global OTC Anti-Infective Drug Market Research Report 2025
Synopsis
Anti-infectives are medicines that work to prevent or treat infections.
The global OTC Anti-Infective Drug market was valued at US$ 22510 million in 2023 and is anticipated to reach US$ 37880 million by 2030, witnessing a CAGR of 8.3% during the forecast period 2024-2030.
The Over-the-Counter (OTC) Anti-Infective Drug market has grown as a convenient option for consumers seeking self-treatment for minor infections. These drugs, available without a prescription, include topical ointments, creams, and oral medications for conditions like skin infections, cold sores, and vaginal infections. The market's expansion is driven by the demand for accessible and cost-effective solutions to address common infections without the need for a doctor's visit. As awareness of self-care and health empowerment increases, the OTC Anti-Infective Drug market continues to offer a range of effective options that enable individuals to manage mild infections quickly and conveniently.
This report aims to provide a comprehensive presentation of the global market for OTC Anti-Infective Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Anti-Infective Drug.
Report Scope
The OTC Anti-Infective Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global OTC Anti-Infective Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OTC Anti-Infective Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
GSK
Teva
Johnson & Johnson
NOVARTIS
MYLAN
Sun Pharma
CR SANJIU
Cipla
Lingrui
Segment by Type
Antifungal
Antibacterial
Antiviral
Antiseptics
Other
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of OTC Anti-Infective Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Anti-infectives are medicines that work to prevent or treat infections.
The global OTC Anti-Infective Drug market was valued at US$ 22510 million in 2023 and is anticipated to reach US$ 37880 million by 2030, witnessing a CAGR of 8.3% during the forecast period 2024-2030.
The Over-the-Counter (OTC) Anti-Infective Drug market has grown as a convenient option for consumers seeking self-treatment for minor infections. These drugs, available without a prescription, include topical ointments, creams, and oral medications for conditions like skin infections, cold sores, and vaginal infections. The market's expansion is driven by the demand for accessible and cost-effective solutions to address common infections without the need for a doctor's visit. As awareness of self-care and health empowerment increases, the OTC Anti-Infective Drug market continues to offer a range of effective options that enable individuals to manage mild infections quickly and conveniently.
This report aims to provide a comprehensive presentation of the global market for OTC Anti-Infective Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding OTC Anti-Infective Drug.
Report Scope
The OTC Anti-Infective Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global OTC Anti-Infective Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the OTC Anti-Infective Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bayer
GSK
Teva
Johnson & Johnson
NOVARTIS
MYLAN
Sun Pharma
CR SANJIU
Cipla
Lingrui
Segment by Type
Antifungal
Antibacterial
Antiviral
Antiseptics
Other
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of OTC Anti-Infective Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global OTC Anti-Infective Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Antifungal
1.2.3 Antibacterial
1.2.4 Antiviral
1.2.5 Antiseptics
1.2.6 Other
1.3 Market by Application
1.3.1 Global OTC Anti-Infective Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global OTC Anti-Infective Drug Market Perspective (2019-2030)
2.2 OTC Anti-Infective Drug Growth Trends by Region
2.2.1 Global OTC Anti-Infective Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 OTC Anti-Infective Drug Historic Market Size by Region (2019-2024)
2.2.3 OTC Anti-Infective Drug Forecasted Market Size by Region (2025-2030)
2.3 OTC Anti-Infective Drug Market Dynamics
2.3.1 OTC Anti-Infective Drug Industry Trends
2.3.2 OTC Anti-Infective Drug Market Drivers
2.3.3 OTC Anti-Infective Drug Market Challenges
2.3.4 OTC Anti-Infective Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top OTC Anti-Infective Drug Players by Revenue
3.1.1 Global Top OTC Anti-Infective Drug Players by Revenue (2019-2024)
3.1.2 Global OTC Anti-Infective Drug Revenue Market Share by Players (2019-2024)
3.2 Global OTC Anti-Infective Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by OTC Anti-Infective Drug Revenue
3.4 Global OTC Anti-Infective Drug Market Concentration Ratio
3.4.1 Global OTC Anti-Infective Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by OTC Anti-Infective Drug Revenue in 2023
3.5 OTC Anti-Infective Drug Key Players Head office and Area Served
3.6 Key Players OTC Anti-Infective Drug Product Solution and Service
3.7 Date of Enter into OTC Anti-Infective Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 OTC Anti-Infective Drug Breakdown Data by Type
4.1 Global OTC Anti-Infective Drug Historic Market Size by Type (2019-2024)
4.2 Global OTC Anti-Infective Drug Forecasted Market Size by Type (2025-2030)
5 OTC Anti-Infective Drug Breakdown Data by Application
5.1 Global OTC Anti-Infective Drug Historic Market Size by Application (2019-2024)
5.2 Global OTC Anti-Infective Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America OTC Anti-Infective Drug Market Size (2019-2030)
6.2 North America OTC Anti-Infective Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America OTC Anti-Infective Drug Market Size by Country (2019-2024)
6.4 North America OTC Anti-Infective Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe OTC Anti-Infective Drug Market Size (2019-2030)
7.2 Europe OTC Anti-Infective Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe OTC Anti-Infective Drug Market Size by Country (2019-2024)
7.4 Europe OTC Anti-Infective Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific OTC Anti-Infective Drug Market Size (2019-2030)
8.2 Asia-Pacific OTC Anti-Infective Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific OTC Anti-Infective Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific OTC Anti-Infective Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America OTC Anti-Infective Drug Market Size (2019-2030)
9.2 Latin America OTC Anti-Infective Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America OTC Anti-Infective Drug Market Size by Country (2019-2024)
9.4 Latin America OTC Anti-Infective Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa OTC Anti-Infective Drug Market Size (2019-2030)
10.2 Middle East & Africa OTC Anti-Infective Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa OTC Anti-Infective Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa OTC Anti-Infective Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer OTC Anti-Infective Drug Introduction
11.1.4 Bayer Revenue in OTC Anti-Infective Drug Business (2019-2024)
11.1.5 Bayer Recent Development
11.2 GSK
11.2.1 GSK Company Detail
11.2.2 GSK Business Overview
11.2.3 GSK OTC Anti-Infective Drug Introduction
11.2.4 GSK Revenue in OTC Anti-Infective Drug Business (2019-2024)
11.2.5 GSK Recent Development
11.3 Teva
11.3.1 Teva Company Detail
11.3.2 Teva Business Overview
11.3.3 Teva OTC Anti-Infective Drug Introduction
11.3.4 Teva Revenue in OTC Anti-Infective Drug Business (2019-2024)
11.3.5 Teva Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson OTC Anti-Infective Drug Introduction
11.4.4 Johnson & Johnson Revenue in OTC Anti-Infective Drug Business (2019-2024)
11.4.5 Johnson & Johnson Recent Development
11.5 NOVARTIS
11.5.1 NOVARTIS Company Detail
11.5.2 NOVARTIS Business Overview
11.5.3 NOVARTIS OTC Anti-Infective Drug Introduction
11.5.4 NOVARTIS Revenue in OTC Anti-Infective Drug Business (2019-2024)
11.5.5 NOVARTIS Recent Development
11.6 MYLAN
11.6.1 MYLAN Company Detail
11.6.2 MYLAN Business Overview
11.6.3 MYLAN OTC Anti-Infective Drug Introduction
11.6.4 MYLAN Revenue in OTC Anti-Infective Drug Business (2019-2024)
11.6.5 MYLAN Recent Development
11.7 Sun Pharma
11.7.1 Sun Pharma Company Detail
11.7.2 Sun Pharma Business Overview
11.7.3 Sun Pharma OTC Anti-Infective Drug Introduction
11.7.4 Sun Pharma Revenue in OTC Anti-Infective Drug Business (2019-2024)
11.7.5 Sun Pharma Recent Development
11.8 CR SANJIU
11.8.1 CR SANJIU Company Detail
11.8.2 CR SANJIU Business Overview
11.8.3 CR SANJIU OTC Anti-Infective Drug Introduction
11.8.4 CR SANJIU Revenue in OTC Anti-Infective Drug Business (2019-2024)
11.8.5 CR SANJIU Recent Development
11.9 Cipla
11.9.1 Cipla Company Detail
11.9.2 Cipla Business Overview
11.9.3 Cipla OTC Anti-Infective Drug Introduction
11.9.4 Cipla Revenue in OTC Anti-Infective Drug Business (2019-2024)
11.9.5 Cipla Recent Development
11.10 Lingrui
11.10.1 Lingrui Company Detail
11.10.2 Lingrui Business Overview
11.10.3 Lingrui OTC Anti-Infective Drug Introduction
11.10.4 Lingrui Revenue in OTC Anti-Infective Drug Business (2019-2024)
11.10.5 Lingrui Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
